Belite Bio Uplists to Nasdaq Global Select Market

AI-generated NewsSnap summary based on source reporting.
Published: 2026-10-19
Category: business
Source: GlobeNewswire

Belite Bio, Inc. (NASDAQ: BLTE) announced it has received approval from Nasdaq to transfer the listing of its securities from the Nasdaq Capital Market to the Nasdaq Global Select Market, effective October 19, 2026. This uplisting reflects compliance with more stringent financial and liquidity standards.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai